Massmutual Trust CO Fsb Neurocrine Biosciences Inc Transaction History
Massmutual Trust CO Fsb
- $3.51 Billion
- Q4 2024
A detailed history of Massmutual Trust CO Fsb transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 531 shares of NBIX stock, worth $77,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531
Previous 374
41.98%
Holding current value
$77,462
Previous $43,000
67.44%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
93.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.07 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.46 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$751 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$376 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$272 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...